To investigate the relationship between SETD2 and MLL-fusions we profiled the global distribution of the SETD2-dependent H3K36me3 mark in a mouse AML cell line expressing MLL-AF9 and activated Nras (G12D)22 using ChIP-Rx45. Here, MLLT3 is linked to acute myeloid leukemia.